The global Ultrasound AI market size was valued at USD 2142.6 million in 2025 and is projected to reach USD 19154.7 million by 2035, expanding at a CAGR of 24.49% from 2026 to 2035. Market growth is supported by increasing adoption of AI-assisted ultrasound imaging, workflow automation, and advancements in deep learning technologies.
Ultrasound AI Market Revenue Forecast, 2022–2035 (US$ Million)
|
Years |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Revenue (USD Mn) |
1081.3 |
XX |
XX |
2142.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
19154.7 |
|
Region |
2022 |
2023 |
2024 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
North America |
XX |
XX |
XX |
1148.4 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
9402.8 |
|
Europe |
XX |
XX |
XX |
439.2 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
3744.6 |
|
Asia Pacific |
XX |
XX |
XX |
398.5 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
4559.9 |
|
Latin America |
XX |
XX |
XX |
70.7 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
674.4 |
|
Middle East & Africa |
XX |
XX |
XX |
85.7 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
773 |
|
|
2025 |
2026 |
2027 |
2028 |
2029 |
2030 |
2031 |
2032 |
2033 |
2034 |
2035 |
|
Conservative |
1081.3 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
9519.5 |
|
Likely |
2142.6 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
19154.7 |
|
Optimistic |
1081.3 |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
XX |
14936.9 |
Technology is increasingly utilized in cardiology, radiology, obstetrics, and emergency medicine, where rapid and accurate diagnosis is critical. Additionally, healthcare systems are prioritizing preventive care and early intervention strategies, further strengthening demand for advanced imaging technologies integrated with artificial intelligence. These trends are encouraging hospitals, diagnostic centers, and outpatient facilities to invest in AI-enhanced ultrasound platforms to improve clinical outcomes and operational efficiency.
The growing prevalence of cardiovascular diseases and other chronic disorders is a major factor driving the adoption of AI-powered ultrasound solutions worldwide. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually. Furthermore, recent projections published in peer-reviewed research indicate that global cardiovascular disease prevalence is expected to increase by nearly 90% between 2025 and 2050. As healthcare providers face increasing patient volumes, there is growing demand for technologies that can improve diagnostic accuracy, reduce interpretation time, and support early disease detection. AI-enabled ultrasound systems address these challenges through automated image analysis, real-time decision support, and workflow optimization.
The rapid growth of the global aging population is creating significant demand for diagnostic imaging services, thereby accelerating adoption of AI-powered ultrasound technologies. According to the Radiological Society of North America (RSNA), by 2030 nearly 20% of the U.S. population, or approximately 70 million people, will be aged 65 years or older. This demographic currently accounts for about 30% of imaging resource utilization annually, with demand continuing to rise. Older populations are more susceptible to cardiovascular diseases, cancer, neurological disorders, and musculoskeletal conditions, all of which require frequent diagnostic imaging and monitoring.
Simultaneously, healthcare systems worldwide are experiencing shortages of radiologists, sonographers, and imaging specialists. AI-enabled ultrasound solutions help address these challenges by automating measurements, improving image quality, assisting with interpretation, and enhancing workflow productivity. Research published in medical journals further highlights the strong correlation between population aging and increased diagnostic imaging utilization. As governments and healthcare organizations focus on improving care delivery for elderly populations, investments in intelligent imaging technologies are expected to accelerate, positioning AI-powered ultrasound as a critical tool for managing future healthcare demands efficiently and cost-effectively.
One of the primary restraints affecting the Ultrasound AI Market is the stringent regulatory approval process and extensive clinical validation requirements associated with AI-enabled medical devices. Regulatory authorities such as the U.S. FDA and European regulators require developers to demonstrate safety, efficacy, transparency, and real-world clinical performance before commercialization. The FDA reports that it has authorized over 1,000 AI/ML-enabled medical devices, the majority of which are related to medical imaging, highlighting the increasing scrutiny placed on AI-based healthcare technologies. However, evolving AI algorithms require continuous updates and monitoring, creating additional regulatory burdens for manufacturers.
Academic studies have shown that fewer than 2% of FDA-approved AI medical devices report retraining updates, partly due to the complexity and cost associated with regulatory reapproval processes. Furthermore, concerns regarding algorithm bias, data drift, reproducibility, and patient safety continue to prompt regulators to demand more rigorous validation frameworks. These requirements often extend product development timelines, increase compliance costs, and delay market entry for emerging ultrasound AI providers. Small and mid-sized companies, in particular, face challenges in generating the large-scale clinical datasets needed to support regulatory submissions and maintain compliance throughout the product lifecycle. As a result, regulatory complexity remains a significant barrier to widespread commercialization and scalability of AI-powered ultrasound technologies.
The regulatory burden associated with AI-enabled medical devices remains a significant challenge for the Ultrasound AI Market. According to the U.S. FDA, more than 1,000 AI-enabled medical devices have been authorized through established regulatory pathways, highlighting the increasing scrutiny and oversight required for AI-based healthcare technologies. The FDA further released dedicated draft guidance in 2025 for AI-enabled medical devices, emphasizing lifecycle management, transparency, and continuous performance monitoring.
These evolving requirements increase development costs, lengthen commercialization timelines, and create barriers for emerging ultrasound AI providers seeking market entry. The need for extensive clinical validation studies, algorithm performance assessments, and post-market surveillance further complicates deployment across healthcare settings. As AI models continue to evolve, manufacturers must invest additional resources to maintain compliance with changing regulatory expectations, slowing product launches and broader market adoption.
The rapid expansion of telemedicine and remote healthcare delivery is creating significant opportunities for the Ultrasound AI Market. AI-powered ultrasound systems are increasingly being integrated with telehealth platforms to enable remote diagnostics, real-time image interpretation, and specialist consultation in underserved regions. According to the Gates Foundation, approximately 4.7 billion people worldwide lack access to medical ultrasound services, while nearly 50% of women in low- and middle-income countries receive no ultrasound examination during pregnancy.
These statistics highlight a substantial unmet need for accessible imaging solutions. AI-assisted ultrasound technologies can reduce operator dependency and enable nurses, primary care providers, and community healthcare workers to perform diagnostic scans with limited specialist support. Furthermore, clinical studies have demonstrated the effectiveness of tele-ultrasound programs in remote locations, improving diagnostic access while reducing unnecessary patient referrals. As governments and healthcare systems continue expanding telehealth infrastructure, AI-enabled ultrasound platforms are expected to play a critical role in bridging healthcare accessibility gaps and improving diagnostic outcomes in rural and underserved communities.
Ultrasound AI Market Share Analysis by Solution, 2025 (%)
|
By Solution |
2025 |
|
Software Tools |
68.7% |
|
Services |
19.5% |
|
Devices |
11.8% |
Software Tools dominated the Ultrasound AI Market due to their widespread use in image interpretation, automated measurements, workflow optimization, and clinical decision support. Healthcare providers increasingly prefer software-based AI solutions because they can be integrated into existing ultrasound systems, improving diagnostic accuracy and operational efficiency without requiring significant hardware replacement investments.
Devices are projected to be the fastest-growing segment, driven by rising adoption of AI-enabled portable ultrasound systems and point-of-care imaging solutions. Advances in embedded AI, handheld ultrasound technology, and real-time imaging guidance are expanding applications across emergency care, primary healthcare, and remote diagnostics, supporting rapid segment growth globally.
Computer Vision held the largest share of the Ultrasound AI Market owing to its critical role in image recognition, anatomy identification, automated measurements, and real-time diagnostic assistance. The technology enhances image quality and supports accurate detection of abnormalities, making it indispensable for radiology, cardiology, obstetrics, and other ultrasound-based clinical applications.
Deep Learning is expected to register the fastest growth due to its superior capability in analyzing complex ultrasound images and identifying subtle disease patterns. Increasing adoption of neural network-based algorithms for automated diagnostics, predictive analytics, and clinical decision support, coupled with advancements in computing power and data availability, is accelerating segment expansion.
Diagnostic Imaging accounted for the largest share of the Ultrasound AI Market due to its extensive use across radiology, cardiology, obstetrics, gynecology, and general imaging applications. AI integration enhances image acquisition, interpretation, and workflow efficiency, enabling faster diagnoses and improved clinical outcomes while supporting the growing demand for accurate, non-invasive diagnostic procedures.
2D / 3D / 4D Ultrasound Imaging is anticipated to be the fastest-growing segment, driven by increasing demand for advanced visualization capabilities and real-time anatomical assessment. AI-powered image enhancement, automated measurements, and improved diagnostic precision are accelerating adoption across prenatal care, cardiovascular imaging, and complex diagnostic applications, particularly in technologically advanced healthcare facilities.
Radiology dominated the Ultrasound AI Market due to the extensive utilization of ultrasound imaging for disease detection, diagnosis, and treatment monitoring. AI-powered radiology solutions improve image interpretation, automate routine tasks, and enhance diagnostic accuracy, enabling healthcare providers to manage increasing imaging volumes while improving workflow efficiency and patient outcomes.
Cardiovascular is expected to be the fastest-growing segment, driven by the rising global prevalence of heart diseases and growing adoption of AI-assisted echocardiography. Advanced AI algorithms support automated cardiac measurements, real-time image analysis, and early detection of cardiovascular abnormalities, helping clinicians improve diagnostic precision and accelerate clinical decision-making.
Hospitals & Clinics accounted for the largest share of the Ultrasound AI Market owing to their high patient volumes, extensive diagnostic imaging requirements, and growing investments in healthcare digitalization. The adoption of AI-powered ultrasound solutions helps improve workflow efficiency, diagnostic accuracy, and clinical decision-making, making hospitals the primary users of advanced ultrasound technologies.
Research Labs and Diagnostics Centers are projected to be the fastest-growing segment due to increasing demand for advanced imaging analytics, early disease detection, and precision diagnostics. Growing investments in AI research, expanding diagnostic testing capabilities, and the need for faster and more accurate imaging interpretation are driving rapid adoption of ultrasound AI solutions in these facilities.
|
By Geography |
2022 |
2025 |
2035 |
|
North America |
XX |
1148.4 |
9402.8 |
|
US |
XX |
1063.4 |
XX |
|
Canada |
XX |
84.9 |
XX |
|
Europe |
XX |
439.2 |
3744.6 |
|
Germany |
XX |
90 |
XX |
|
UK |
XX |
56.2 |
XX |
|
France |
XX |
68.5 |
XX |
|
Italy |
XX |
37.7 |
XX |
|
Spain |
XX |
36 |
XX |
|
Switzerland |
XX |
13.6 |
XX |
|
Netherlands |
XX |
9.2 |
XX |
|
Rest of Europe |
XX |
127.8 |
XX |
|
Asia Pacific |
XX |
398.5 |
4559.9 |
|
China |
XX |
166.9 |
XX |
|
India |
XX |
30.2 |
XX |
|
Japan |
XX |
62.9 |
XX |
|
South Korea |
XX |
56.9 |
XX |
|
Singapore |
XX |
14.3 |
XX |
|
Australia |
XX |
20.7 |
XX |
|
Thailand |
XX |
5.1 |
XX |
|
Malaysia |
XX |
9.9 |
XX |
|
Philippines |
XX |
7.9 |
XX |
|
Indonesia |
XX |
6.3 |
XX |
|
Rest of Asia Pacific |
XX |
16.7 |
XX |
|
Middle East & Africa |
XX |
85.7 |
773 |
|
Saudi Arabia |
XX |
28.1 |
XX |
|
United Arab Emirates |
XX |
22.1 |
XX |
|
South Africa |
XX |
12.9 |
XX |
|
Egypt |
XX |
7 |
XX |
|
Israel |
XX |
6.1 |
XX |
|
Rest of MEA |
XX |
9.2 |
XX |
|
Latin America |
XX |
70.7 |
674.4 |
|
Brazil |
XX |
23.2 |
XX |
|
Mexico |
XX |
16.6 |
XX |
|
Argentina |
XX |
7.4 |
XX |
|
Chile |
XX |
6 |
XX |
|
Colombia |
XX |
3.6 |
XX |
|
Peru |
XX |
3 |
XX |
|
Rest of LA |
XX |
10.5 |
XX |
North America Ultrasound AI market held the largest share of 53.6% of the global market in 2025 and was valued at approximately USD 1148.4 million. Growth is driven by strong healthcare digitization, expanding AI investments, advanced imaging infrastructure, and favourable reimbursement frameworks.
The U.S. accounted for the dominant share within North America and represented approximately 92.6% of the regional market in 2025. Market expansion is fueled by rapid AI innovation, increasing diagnostic imaging volumes, and widespread adoption of smart healthcare solutions.
Canada represented approximately 7.4% of the North American market in 2025 and was valued at around USD 84.9 million. Growth is supported by digital health initiatives, rising telemedicine adoption, and increasing demand for accessible diagnostic services.
Europe accounted for approximately 20.5% of the global Ultrasound AI market in 2025 and was valued at nearly USD 439.2 million. Market growth benefits from healthcare modernization, growing AI integration in diagnostics, and increasing emphasis on operational efficiency.
The UK represented approximately 12.8% of the European market in 2025 and was valued at nearly USD 56.2 million. Expansion is driven by advanced healthcare infrastructure, strong medical technology capabilities, and increasing AI-enabled imaging adoption.
Germany accounted for approximately 20.5% of the European market in 2025 and was valued at around USD 90 million. Growth is supported by NHS digital transformation programs, rising imaging demand, and increasing deployment of clinical AI tools.
The France represented approximately 15.6% of the European market in 2025 and was valued at nearly USD 68.5 million. Market growth is fueled by healthcare digitization efforts, increasing investments in diagnostic technologies, and early disease detection initiatives.
Italy accounted for approximately 8.6% of the European market in 2025 and was valued at around USD 37.7 million. Expansion is supported by growing chronic disease burden, healthcare modernization projects, and rising utilization of AI diagnostics.
The Spain represented approximately 8.2 % of the European market in 2025 and was valued at nearly USD 36 million. Growth is driven by increasing healthcare technology investments, expanding smart hospital projects, and growing demand for imaging efficiency.
Switzerland accounted for approximately 3.1 % of the European market in 2025 and was valued at around USD 13.6 million. Market growth benefits from high healthcare expenditure, strong innovation capabilities, and growing precision medicine adoption.
The Netherlands represented approximately 2.1 % of the European market in 2025 and was valued at nearly USD 9.2 million. Expansion is supported by advanced digital healthcare infrastructure, innovation-friendly policies, and increasing AI implementation across hospitals.
Asia-Pacific accounted for approximately 18.6% of the global market in 2025 and was valued at nearly USD 398.5 million. Growth is driven by healthcare digitalization, expanding patient populations, increasing imaging demand, and improving healthcare accessibility.
China represented approximately 41.9 % of the Asia-Pacific market in 2025 and was valued at around USD 166.9 million. Market expansion is fueled by government-backed AI initiatives, smart hospital development, and strong domestic healthcare innovation.
India accounted for approximately 7.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 30.2 million. Growth is supported by expanding healthcare access, rising diagnostic requirements, and increasing adoption of portable ultrasound technologies.
Japan represented approximately 15.8 % of the Asia-Pacific market in 2025 and was valued at around USD 62.9 million. Expansion is driven by aging demographics, growing healthcare automation needs, and increasing deployment of advanced imaging solutions.
South Korea represented approximately 14.3 % of the Asia-Pacific market in 2025 and was valued at around USD 56.9 million. Market growth benefits from strong AI ecosystems, smart healthcare investments, and rapid adoption of digital medical technologies.
Singapore accounted for approximately 3.6 % of the Asia-Pacific market in 2025 and was valued at nearly USD 14.3 million. Growth is supported by advanced healthcare infrastructure, government AI initiatives, and increasing focus on healthcare innovation.
Australia represented approximately 5.2 % of the Asia-Pacific market in 2025 and was valued at around USD 20.7 million. Expansion is fueled by demand for remote healthcare services, telehealth growth, and increasing healthcare technology investments.
Thailand represented approximately 1.3 % of the Asia-Pacific market in 2025 and was valued at around USD 5.1 million. Growth is driven by healthcare modernization efforts, medical tourism expansion, and increasing demand for diagnostic efficiency.
Malaysia accounted for approximately 2.5 % of the Asia-Pacific market in 2025 and was valued at nearly USD 9.9 million. Market growth is supported by healthcare transformation programs, rising digital health adoption, and growing diagnostic imaging utilization.
Philippines represented approximately 2 % of the Asia-Pacific market in 2025 and was valued at around USD 7.9 million. Expansion is driven by healthcare infrastructure development, increasing disease burden, and rising adoption of telemedicine solutions.
Indonesia represented approximately 1.6 % of the Asia-Pacific market in 2025 and was valued at around USD 6.3 million. Growth is supported by expanding healthcare coverage, digital health initiatives, and increasing demand for diagnostic imaging services.
Middle East & Africa accounted for approximately 4% of the global market in 2025 and was valued at nearly USD 85.7 million. Market growth benefits from healthcare infrastructure investments, digital transformation initiatives, and growing demand for advanced diagnostics.
Saudi Arabia accounted for approximately 32.8 % of the Middle East market in 2025 and was valued at nearly USD 28.1 million. Expansion is driven by Vision 2030 healthcare reforms, smart hospital projects, and increasing investments in healthcare technologies.
United Arab Emirates represented approximately 25.9 % of the Middle East market in 2025 and was valued at around USD 22.1 million. Growth is supported by AI-focused healthcare strategies, advanced medical facilities, and increasing digital health adoption.
South Africa represented approximately 15.1 % of the Middle East market in 2025 and was valued at around USD 12.9 million. Market expansion is fueled by rising chronic disease prevalence, private healthcare investments, and growing diagnostic requirements.
Egypt accounted for approximately 8.2 % of the Middle East & Africa market in 2025 and was valued at nearly USD 7 million. Growth is driven by healthcare modernization programs, increasing population healthcare needs, and expanding technology adoption.
Israel represented approximately 7.2 % of the Middle East and Africa market in 2025 and was valued at around USD 6.1 million. Expansion is supported by strong healthcare innovation, advanced AI research capabilities, and growing commercialization of medical technologies.
Latin America accounted for approximately 3.3% of the global market in 2025 and was valued at around USD 70.7 million. Market growth is driven by healthcare digitalization, increasing diagnostic demand, and expanding private healthcare investments.
Brazil accounted for approximately 32.9 % of the Latin America market in 2025 and was valued at nearly USD 23.2 million. Growth is supported by large patient populations, expanding diagnostic networks, and increasing healthcare technology adoption.
Mexico accounted for approximately 23.5 % of the Latin America market in 2025 and was valued at nearly USD 16.6 million. Expansion is fueled by healthcare infrastructure development, rising chronic disease incidence, and growing demand for imaging solutions.
Argentina represented approximately 10.6 % of the Latin America market in 2025 and was valued at around USD 7.4 million. Market growth benefits from increasing healthcare modernization efforts, diagnostic imaging demand, and digital healthcare adoption.
Chile represented approximately 8.6 % of the Latin America market in 2025 and was valued at around USD 6 million. Growth is driven by healthcare innovation investments, digital transformation initiatives, and increasing preventive healthcare focus.
Colombia accounted for approximately 5.2 % of the Latin America market in 2025 and was valued at nearly USD 3.6 million. Expansion is supported by broader healthcare coverage, rising healthcare investments, and growing adoption of diagnostic technologies.
Peru represented approximately 4.3 % of the Latin America market in 2025 and was valued at around USD 3 million. Market growth is fueled by healthcare accessibility improvements, increasing diagnostic requirements, and expanding digital health initiatives.
|
Company |
Share |
|
Siemens Healthineers |
14.80% |
|
General Electric |
13.90% |
|
Samsung |
10.70% |
|
Butterfly Network |
8.40% |
|
EchoNous |
7.20% |
Our research framework segments the Ultrasound AI market by Solution, Technology, Ultrasound Technology, Application, End User, and key regional markets
By Solution
By Technology
By Ultrasound Technology
By Application
By End User
By Region & Country
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
|
Key Report Attributes |
Details |
|
Years Considered |
2022 to 2035 |
|
Market Size 2025 |
USD 2142.6 Million |
|
Market Size 2035 |
USD 19154.7 Million |
|
Historical CAGR % (Growth rate) |
XX% from 2022 to 2025 |
|
Futuristic CAGR % (Growth rate) |
24.49% from 2026 to 2035 |
|
Segments Covered |
· By Solution · By Technology · By Ultrasound Technology · By Application · By End User |
|
Regions Covered |
· North America · Europe · Asia Pacific · Latin America · Middle East & Africa |
|
Countries Covered |
USA; Canada; Germany; United Kingdom; France; Italy; Spain; Switzerland; Netherlands; China; India; Japan; South Korea; Singapore; Australia; Thailand; Malaysia; Philippines; Indonesia; Saudi Arabia; United Arab Emirates; South Africa; Egypt; Israel; Brazil; Mexico; Argentina; Chile; Colombia; Peru |
|
Competitive Landscape Overview |
· Agfa-Gevaert · Butterfly Network · CloudMedx · Enlitic · EchoNous · General Vision · GENERAL ELECTRIC · Intel · IBM · Imagia Cybernetic · Johnson & Johnson · NVIDIA · Microsoft · Medtronic · Micron Technology · Siemens Healthineers · SAMSUNG |
|
Flexible Report Customization |
The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights. |
|
Data Sources |
Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more. |
By Solution
By Technology
By Ultrasound Technology
By Application
By End User
+44 1313818849
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
INDIA OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
408B, City Center, Hadapsar, Pune, India 411028
FOLLOW US
© Copyright 2026-27 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®